Brief: Rallybio Announces Portfolio Prioritization And Provides Corporate Update

Rallybio

06/02/2024 14:39

Feb 6 (Reuters) - Rallybio Corp  RLYB.O :
    * RALLYBIO ANNOUNCES PORTFOLIO PRIORITIZATION AND PROVIDES
CORPORATE UPDATE
    * RALLYBIO CORP - ANTICIPATED COST SAVINGS, INCLUDING A 45%
WORKFORCE REDUCTION, EXTENDS CASH RUNWAY INTO MID-2026
    * RALLYBIO CORP: EXPECTS TO EXTEND CASH RUNWAY INTO MID-2026
    * RALLYBIO CORP: WILL IMPLEMENT A 45% WORKFORCE REDUCTION,
REPRESENTING 19 POSITIONS, WHICH WILL BE SUBSTANTIALLY COMPLETE
BY END OF Q1 OF 2024
    * RALLYBIO CORP: ESTIMATES THAT WORKFORCE REDUCTION WILL
RESULT IN
AGGREGATE CHARGES OF APPROXIMATELY $3.3 MILLION
    * RALLYBIO CORP - PLANS TO PROVIDE AN UPDATE ON PHASE 2
DISCUSSIONS FOR RLYB212 WITH EUROPEAN MEDICINES AGENCY (EMA) IN
FIRST HALF OF 2024
    * RALLYBIO- CONTINUES TO EXPECT TO INITIATE A PHASE 2 DOSE
CONFIRMATION STUDY FOR RLYB212 IN PREGNANT WOMEN AT HIGHER RISK
OF FNAIT IN H2 2024

Source text for Eikon:  ID:nBw8Vw8Tma 
Further company coverage:  RLYB.O 

 ((Reuters.Briefs@thomsonreuters.com;))